A three-drug regimen is recommended for multibacillary leprosy (lepromatous, borderline-lepromatous, and borderline leprosy) and a two-drug regimen for paucibacillary leprosy (borderline-tuberculoid, tuberculoid, and indeterminate). Multibacillary leprosy should be treated with a combination of rifampicin, dapsone and clofazimine for at least 2
Multidrug therapy (MDT) is the treatment of choice for all leprosy patients. It entails the swallowing of a combination of anti-leprosy drugs on a daily basis.
WHO recommended multidrug therapy (MDT) regimens. The Guidelines for the diagnosis, treatment and prevention of leprosy (WHO, 2024), recommends the same 3-drug regimen with rifampicin, dapsone and clofazimine for all leprosy patients, with a duration of treatment of 6 months for PB leprosy and of 12 months for MB leprosy.
Leprosy is curable with a combination of drugs known as multidrug therapy (MDT), as the treatment of leprosy with only one anti-leprosy drug (monotherapy)
Leprosy is curable with a combination of drugs known as multidrug therapy (MDT), as the treatment of leprosy with only one anti leprosy drug (monotherapy) will result in development of drug resistance to that drug. The combination of drugs used in the MDT depends on the classification of the disease.
by VM Katoch Cited by 42alternative drug treatment for MB leprosy (Refs. 66, 67). However, experience drugs in leprosy and leprosy reactions. Lepr Rev. 71 Suppl, S
Anti-leprotic drugs The drugs which are used in the treatment of leprosy are termed antileprotic drugs. Leprosy is an infectious disease caused by a bacillus, Mycobacterium leprae. Leprosy is an infectious disease caused by a bacillus, Mycobacterium leprae.
Multidrug therapy (MDT) is the treatment of choice for all leprosy patients. It entails the swallowing of a combination of anti-leprosy drugs on a daily basis.
Leprosy is curable with a combination of drugs known as multi-drug therapy (MDT), as the treatment of leprosy with only one antileprosy drug (monotherapy) will result in development of drug resistance to that drug. The combination of drugs used in the MDT depends on the classification of the disease (paucibacillary or multibacillary leprosy).
Comments